Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL) × ponatinib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL) 1

Interventions

ponatinib 1 Vincristine 1 Prednisone 1 Methotrexate 1 Imatinib Mesylate 1 Dexamethasone 1 Cytarabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03589326 2025-11-26

A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia

Takeda

Phase 3 Active not recruiting

245 enrolled 15 charts 2 FDA

LymphoidOther hematologic neoplasm

Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)

Data powered by HemOnc (CC BY 4.0) Colophon ⚡